2020
DOI: 10.1038/s41598-020-64428-z
|View full text |Cite
|
Sign up to set email alerts
|

IFN-γ and IgG responses to Mycobacterium tuberculosis latency antigen Rv2626c differentiate remote from recent tuberculosis infection

Abstract: tuberculin skin test (tSt) and ifn-γ release assays are currently used to detect Mycobacterium tuberculosis (Mtb) infection but none of them differentiate active from latent infection (LTBI). Since improved tests to diagnose Mtb infection are required, we studied the immune response to Mtb latency antigen Rv2626c in individuals exposed to the bacteria during different periods. Tuberculosis patients (TB), TB close contacts (CC: subjects exposed to Mtb for less than three months) and healthcare workers (HW: indi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 28 publications
1
10
0
1
Order By: Relevance
“…Furthermore, in patients with long-term LTBIs, higher percentages of IFN-γ + TNF-α + CD8 + T cells were found in response to Rv2031c protein in comparison with PPD − controls, with the most frequent memory phenotype of these cells being effector memory (CCR7 − CD45RA − ) T cells, followed by effector (CCR7 − CD45RA + ) T cells (Commandeur et al, 2011), which is consistent with an essential role of CD8 + T cells in defending the host from M. tuberculosis infection (Bruns et al, 2009). The Rv2626c antigen induced significantly higher levels of IFN-γ in QFT + individuals or healthy household contacts than in QFT − individuals or patients with TB and had the ability to differentiate individuals with LTBI from healthy controls and patients with TB, with 78.95% sensitivity and 83.02% specificity (Prabhavathi et al, 2015;Amiano et al, 2020), which is consistent with the sensitivity (77.1%) and specificity (85.1%) of Rv2626c reported in another study (Ashraf et al, 2014).…”
Section: Novel Biomarkers Derived From Mycobacterium Tuberculosissupporting
confidence: 58%
“…Furthermore, in patients with long-term LTBIs, higher percentages of IFN-γ + TNF-α + CD8 + T cells were found in response to Rv2031c protein in comparison with PPD − controls, with the most frequent memory phenotype of these cells being effector memory (CCR7 − CD45RA − ) T cells, followed by effector (CCR7 − CD45RA + ) T cells (Commandeur et al, 2011), which is consistent with an essential role of CD8 + T cells in defending the host from M. tuberculosis infection (Bruns et al, 2009). The Rv2626c antigen induced significantly higher levels of IFN-γ in QFT + individuals or healthy household contacts than in QFT − individuals or patients with TB and had the ability to differentiate individuals with LTBI from healthy controls and patients with TB, with 78.95% sensitivity and 83.02% specificity (Prabhavathi et al, 2015;Amiano et al, 2020), which is consistent with the sensitivity (77.1%) and specificity (85.1%) of Rv2626c reported in another study (Ashraf et al, 2014).…”
Section: Novel Biomarkers Derived From Mycobacterium Tuberculosissupporting
confidence: 58%
“…Other approaches for the characterization of this subset (e.g., measurement of other cytokines or multimeric tetramer staining) should be considered. And second, the immune status of each patient depends on multiple parameters, involving not only host and pathogen genetics but also the age of the host (Veneri et al, 2009), the length and type of antibiotic treatment and the recency of infection (Amiano et al, 2020), among others. Therefore, it is necessary to take into account the inherent heterogeneity of the patients when translating potential biomarkers into clinical applications.…”
Section: Discussionmentioning
confidence: 99%
“…En nuestro país, en el Laboratorio de Inmunidad y Tuberculosis (IQUIBICEN, CONICET -UBA) se ha desarrollado un método diagnóstico de tipo IGRA (Diagnos-TB) similar a QuantiFERON pero mejorado por la inclusión de un tubo extra que permite la diferenciación de individuos LTBI de individuos sanos, pacientes con TB e individuos recientemente expuestos a M. tuberculosis, con una sensibilidad del 79% y una especificidad del 83%. 31 El mismo será ofrecido en un futuro próximo como Servicio Tecnológico de Alto Nivel (STAN -IQUIBICEN: www. iquibicen.fcen.uba.ar) para la comunidad a un costo netamente inferior al de las pruebas IGRA importadas.…”
Section: Igra Para Identificar Infección Latente En Pacientes Inmunoc...unclassified